Join Dr. Michael Boice from Certis Oncology for a discussion and demonstration of how artificial intelligence can improve preclinical decision-making in cancer research.
Molecular profiling and other tumor model characterization data are becoming increasingly important to preclinical decision-making. During this presentation, you'll experience first-hand how the latest in AI/ML tools are revolutionizing cancer research and early drug development by:
- Optimizing preclinical model selection.
- Informing biomarker, drug repurposing, and label expansion strategies.
- Enabling quick in silico analysis of complex datasets to provide insights into therapeutic efficacy and drug response.
- Simplifying data retrieval and enable efficient, ad hoc analyses for research teams.
Eligible attendees will receive access to an exciting new generative AI tool developed exclusively for cancer researchers.
Presenters
Michael Boice
Michael Boice, PhD, has over 20 years of experience in translational oncology drug development. Michael’s areas of scientific expertise include the development of novel oncology therapeutics, functional genomics and rare cancers. At Certis, he works directly with clients to enhance their discovery efforts through translational science discussions, optimizing the customer experience. He holds a PhD in Pharmacology from Weill Cornell Graduate School of Medical Sciences, Department of Pharmacology Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics.
Sponsor
Certis Oncology Solutions, Inc.
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
